PHARMACOLOGICAL PROPERTIES OF YM-21095, A POTENT AND HIGHLY SPECIFIC RENIN INHIBITOR

被引：7

作者：

SHIBASAKI, M

ASANO, M

FUKUNAGA, Y

USUI, T

ICHIHARA, M

MURAKAMI, Y

NAKANO, K

FUJIKURA, T

机构：

[1] Central Research Laboratories, Applied Pharmacology Development Laboratories Yamanouchi Pharmaceutical Co Ltd.

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1991年 / 4卷 / 12期

关键词：

HUMAN RENIN INHIBITOR; HYPOTENSION; SQUIRREL MONKEY;

D O I：

10.1093/ajh/4.12.932

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

A novel renin inhibitor, YM-21095 ((2RS), (3S)-3-[N-alpha[1,4-dioxo-4-morpholino-2-(1-naphthylmethyl)-buthyl]-L-histidil-amino]-4-cyclohexyl-1-[(1-methyl-5-tetrazolyl)thio]-2-butanol), has been synthesized in our laboratories. The aim of this study was to evaluate the pharmacological properties of YM-21095 in in vitro and in vivo experiments. YM-21095 inhibited human renin with an IC-50 value of 4.7 x 10(-10) mol/L. YM-21095 was also a potent inhibitor against squirrel monkey renin, but less effective against renins from dog, rabbit, and rat. The effect of YM-21095 is highly specific for renin, since it did not inhibit cathepsin D, pepsin, or angiotensin converting enzyme up to a concentration of 10(-4) mol/L. YM-21095 was resistant to proteolytic actions of the enzymes (pepsin, chymotrypsin, trypsin) and squirrel monkey tissue homogenates (liver, kidney, small intestine). Intravenous infusion of YM-21095 (0.1 to 100-mu-g/kg/min) decreased mean blood pressure and inhibited plasma renin activity in a dose-dependent manner with no effect on heart rate in anesthetized sodium-depleted and sodium-replete squirrel monkeys. The hypotensive effect of YM-21095 in sodium-depleted squirrel monkeys was about ten times as potent as that in sodium-replete squirrel monkeys. Oral administration of YM-21095 to conscious sodium-depleted squirrel monkeys produced dose-related decreases of systolic blood pressure. We conclude that YM-21095 is a potent and highly specific inhibitor of primate renin and produces a blood pressure lowering effect.

引用

页码：932 / 938

页数：7

共 15 条

[11]

Kleinert H.D., Martin D., Chekal M.A., Et al., Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity, Hypertension, 11, pp. 613-619, (1988)

[12]

Pals D.T., Degraaf G.L., Kati W.M., Et al., Cardiovascular effects of a renin inhibitor in relation to posture in nonhuman primate, Clin Exper Hypertens A, 7, pp. 105-121, (1985)

[13]

Keeton T.K., Campbell W.B., The pharmacological alteration of renin release, Pharmacol Rev, 31, pp. 81-227, (1981)

[14]

Cha S., Tight-binding inhibitors: I. Kinetic behavior, Bio-Chem Pharmacol, 24, pp. 2177-2185, (1975)

[15]

Macgregor G.A., Markandu N.D., Smith S.J., Et al., Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man, Clin Exp Hypertens [A], 5, pp. 1367-1380, (1983)

← 1 2 →